M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.78 EUR -1.02% Market Closed
Market Cap: 108.1m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Income Statement

Earnings Waterfall
Maat Pharma SA

Revenue
2.6m EUR
Cost of Revenue
-826k EUR
Gross Profit
1.7m EUR
Operating Expenses
-25.9m EUR
Operating Income
-24.2m EUR
Other Expenses
27k EUR
Net Income
-24.1m EUR

Income Statement
Maat Pharma SA

Rotate your device to view
Income Statement
Currency: EUR
Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
1
N/A
1
+11%
1
+32%
2
+62%
2
-4%
3
+15%
Gross Profit
Cost of Revenue
(0)
(0)
(0)
(1)
(1)
(1)
Gross Profit
1
N/A
1
+5%
1
+29%
2
+62%
2
-6%
2
+5%
Operating Income
Operating Expenses
(10)
(13)
(15)
(16)
(22)
(26)
Selling, General & Administrative
(3)
(4)
(4)
(5)
(5)
(6)
Research & Development
(9)
(12)
(14)
(17)
(21)
(24)
Other Operating Expenses
2
3
4
5
5
4
Operating Income
(9)
N/A
(12)
-38%
(14)
-10%
(15)
-9%
(20)
-35%
(24)
-21%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(0)
(0)
(1)
Total Other Income
(0)
(0)
(0)
0
1
1
Pre-Tax Income
(9)
N/A
(12)
-37%
(14)
-11%
(15)
-7%
(20)
-34%
(24)
-22%
Net Income
Income from Continuing Operations
(9)
(12)
(14)
(15)
(20)
(24)
Net Income (Common)
(9)
N/A
(12)
-37%
(14)
-11%
(15)
-7%
(20)
-34%
(24)
-22%
EPS (Diluted)
-0.91
N/A
-1.23
-35%
-1.39
-13%
-1.32
+5%
-1.73
-31%
-1.97
-14%

See Also

Discover More